cgmp compliance Options
No. 21 CFR 211.113(a) requires acceptable prepared techniques for being recognized and followed in the course of manufacturing to avoid objectionable microorganisms in drug merchandise not required to be sterile. In addition, the second paragraph of USP Standard Chapter Antimicrobial Efficiency Screening reads: Antimicrobial preservatives